Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical response
Safae Hamkour, Eefje HM van der Heijden, Ana P Lopes, Sofie L M Blokland, Cornelis P J Bekker, Cornelia G Van Helden-Meeuwsen, Marjan A Versnel, Aike A Kruize, Timothy RDJ Radstake, Helen L Leavis, Maarten R Hillen, Joel AG van Roon
RMD Open Aug 2023, 9 (3) e002979; DOI: 10.1136/rmdopen-2023-002979